Skip to main content
logo
Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
20.40
-0.55 (-2.63%)
Apr 16, 2026, 4:00 PM EDT - Market closed

Caris Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Cap
5,7657,623---
Enterprise Value
5,3947,201000
Last Close Price
20.4026.98---
PE Ratio
--8.38---
PS Ratio
7.109.39---
PB Ratio
9.982.44---
P/TBV Ratio
1.161.44---
P/FCF Ratio
86.17113.95---
P/OCF Ratio
69.3291.67---
EV/Sales Ratio
6.648.87---
EV/EBITDA Ratio
79.64106.33---
EV/EBIT Ratio
119.56159.63---
EV/FCF Ratio
80.63107.65---
Debt / Equity Ratio
0.120.12-1.15-8.460.67
Debt / EBITDA Ratio
5.605.60-1.82-0.62-0.83
Debt / FCF Ratio
5.675.67-1.50-0.56-0.68
Net Debt / Equity Ratio
-0.13-0.13-0.12-0.020.11
Net Debt / EBITDA Ratio
-6.22-6.22-1.50-0.150.72
Net Debt / FCF Ratio
-6.29-6.29-1.23-0.140.58
Asset Turnover
1.111.111.090.540.36
Inventory Turnover
5.295.295.274.523.80
Quick Ratio
7.177.170.941.903.31
Current Ratio
7.857.851.302.553.77
Return on Equity (ROE)
-4.78%-4.78%189.92%-293.83%-127.28%
Return on Assets (ROA)
6.14%6.14%-67.96%-56.54%-44.01%
Return on Invested Capital (ROIC)
24.43%24.43%-141.47%-154.94%-143.70%
Return on Capital Employed (ROCE)
7.67%7.67%-103.66%-71.15%-54.39%
Earnings Yield
-9.33%-11.93%---
FCF Yield
1.16%0.88%---
Buyback Yield / Dilution
-371.04%-371.05%-1.59%-104626.10%-
Total Shareholder Return
-371.04%-371.05%-1.59%-104626.10%-
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q